Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAREYDRUGS Aarey Drugs & Pharmaceuticals Ltd NSE:AAREYDRUGS
62 GF Score
Price ₹98.89
GF Value ₹52.85
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Aarey Drugs & Pharmaceuticals FFO?

FFO (Funds from operations) only applies to REITs.

NSE:AAREYDRUGS
62GF Score
Aarey Drugs & Pharmaceuticals Ltd NSE:AAREYDRUGS
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aarey Drugs & Pharmaceuticals (NSE:AAREYDRUGS) Overvalued in 2026?

Based on GuruFocus' analysis, Aarey Drugs & Pharmaceuticals stock appears to be overvalued. The current stock price of ₹98.89 is trading 87.1% above its estimated GF Value™ of ₹52.85. GuruFocus considers Aarey Drugs & Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:AAREYDRUGS:

  • FFO:
  • GF Value™: ₹52.85 vs. price of ₹98.89 (87.1% above fair value)
  • GF Score™: 62/100 with 8 warning signs

No single metric tells the full story. See the NSE:AAREYDRUGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aarey Drugs & Pharmaceuticals Business Description

Other Exchanges 524412:India
Address 340/348, Narshi Natha Street, 107, Sahakar Bhavan, Masjid Bunder, Mumbai, MH, IND, 400 009
Aarey Drugs & Pharmaceuticals Ltd is engaged in bulk drug manufacturing and offers products for industrial applications. The company manufactures active pharmaceutical ingredients, intermediates, and specialty chemicals. It is also involved in the trading of industrial solvents and chemicals. The products offered by the company include N-Methyl urea, Dimethyl urea, Mefenamic acid, Metformin, Doxaphylline, and BMD among others. The company principally carries out its business operations in India.
62GF Score

Get the complete analysis for NSE:AAREYDRUGS

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.89
Price
₹52.85
GF Value